Vincent La Terza has been promoted to associate vice-president of research and director of technology transfer and commercialisation at Georgia State.
Vincent La Terza (pictured), assistant vice-president and senior licensing agent at Georgia State University (GSU), was promoted to associate vice-president of research and director of technology transfer and commercialisation on Thursday.
He will head the institution’s tech transfer arm, Office of Technology Licensing and Commercialization. His new appointment comes less than a year after he joined GSU in May 2017.
La Terza has previously also worked in technology transfer for Georgia Institute of Technology, University of Georgia and Emory University, where he served as the institution’s first director of technology transfer from 1991 to 1998.
Apart from also being an attorney, La Terza has co-founded and led a range of biopharmaceutical companies, including Octagen, Abeome, Neurop, Haplomics and, most recently, Aiye Biopharma.
In addition to La Terza’s promotion, Georgia State has also hired Nathanael McCurley as a licensing associate. McCurley was most recently a senior scientist at vaccine developer GeoVax and holds a PhD in immunobiology from Yale University.
James Weyhenmeyer, vice-president of research and economic development at Georgia State, said: “We are delighted to name Vince La Terza as head of the technology and commercialisation office.
“Vince has deep experience in moving innovation to market through direct licensing and early-stage company development.”
– Image courtesy of Georgia State University